ASCO 2020: FAK Inhibition May Improve Outcomes in NF2 Mutation-Positive Meningioma
Most responses were stable disease using investigational GSK2256098
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Most responses were stable disease using investigational GSK2256098
Only registered members have full access to PracticeUpdate content.